Axxion S.A.’s Amgen AMGN Stock Holding History

Axxion S.A.’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$713K	Buy	+1,968	New	+$674K	0.05%	188

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Axxion S.A.'s AMGN Position: Q2 2026 in Review

Axxion S.A. opened a new position in Amgen (AMGN) in Q2 2026: 1,968 shares worth $713K. The stake represents 0.05% of the portfolio and ranks #188 among its holdings.

3,010 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Axxion S.A. held 1,968 shares of Amgen worth $713K as of Q2 2026.
Amgen was a new Axxion S.A. position in Q2 2026.
Amgen made up 0.05% of Axxion S.A.'s portfolio in Q2 2026, its #188 holding.
3,010 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Axxion S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.